Pre-Exposure Prophylaxis to Prevent HIV- Still With Limited Uptake

I previously blogged about the use of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine (Truvada) prior to high risk behaviors to prevent HIV transmission. 

Here is a recent analysis on PrEP suggesting that despite the presumed efficacy of the intervention, uptake by infectious diseases physicians is limited. In this survey, although a majority of clinicians supported PrEP, only 9% had actually provided it. 

As suggested by the article, we may not be "prepped for PrEP''.